Casein Kinase 2
Casein kinase II (CK2) is a constitutively active, ubiquitously expressed serine/threonine protein kinase thought to have a regulatory function in cell proliferation, differentiation and apoptosis. CK2 functions as a tetrameric complex with 2 regulatory and 2 catalytic subunits.
Casein Kinase 2 Inhibitors |
|
---|---|
Cat. No. | Product Name / Activity |
7450 | SGC CK2-1 |
Potent CK2A2 and CK2A1 inhibitor; also inhibits DYRK2 | |
2275 | TBB |
Selective cell-permeable CK2 inhibitor | |
2825 | TBCA |
Selective CK2 inhibitor | |
4432 | TTP 22 |
High affinity, selective CK2 inhibitor |
Casein kinase II (CK2) is a constitutively active, ubiquitously expressed serine/threonine protein kinase that is thought to have a regulatory function in cell proliferation, cell differentiation and apoptosis. CK2 functions as a tetrameric complex consisting of two regulatory β-subunits and two catalytic units (α and α′) in a homomeric or heteromeric conformation.
Whilst the α- and α′-subunits are catalytically identical, proteins that regulate CK2, such as cdc2 and Hsp90, preferentially bind to the α- and not the α′-subunit. CK2 can phosphorylate a number of key intracellular signaling proteins implicated in tumor suppression (p53 and PTEN) and tumorigenesis (Myc, Jun, NF-κB). CK2 is also thought to influence Wnt signaling via β-catenin phosphorylation, and the PI 3-K signaling pathway via the phosphorylation of Akt.
External sources of pharmacological information for Casein Kinase 2 :
Literature for Casein Kinase 2
Tocris offers the following scientific literature for Casein Kinase 2 to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cell Cycle and DNA Damage Research Product Guide
This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:
- Cell Cycle and Mitosis
- DNA Damage Repair
- Targeted Protein Degradation
- Ubiquitin Proteasome Pathway
- Chemotherapy Targets
Casein Kinase 2 (CK2) Gene Data
Gene | Species | Gene Symbol | Gene Accession No. | Protein Accession No. |
---|---|---|---|---|
CK2α | Human | CSNK2A1 | NM_001895 | P68400 |
Mouse | Csnk2a1 | NM_007788 | Q60737 | |
Rat | Csnk2a1 | NM_053824 | P19139 | |
CK2α′ | Human | CSNK2A2 | NM_001896 | P19784 |
Mouse | Csnk2a2 | NM_009974 | O54833 | |
CK2β | Human | CSNK2B | NM_001320 | P67870 |
Mouse | Csnk2b | NM_009975 | P67871 | |
Rat | Csnk2b | NM_001035238 | P67874 |